Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric Cancer: an Exploratory Multicenter Prospective Observational Clinical Study

NCT05956847 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05956847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05956847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric Cancer: an Exploratory Multicenter Prospective Observational Clinical Study
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 10, 2023
Completion date
July 30, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extrachromosomal dna, gastric cancer, precancerous lesion of digestive tract